Dynamic Drug Discovery
Latest round
- Seed
Last raised
- Oct 2022
Total raised
- $0.1M
Investors
- 1
About Dynamic Drug Discovery
Based in Daejeon, South Korea, and founded in 2022, Dynamic Drug Discovery formerly known as Dementia Drug Discovery, operates as a pharmaceutical company that develops DAPPD, a drug treatment. Dynamic Drug Discovery develops DAPPD for neuroinflammation-modified Tylenol's structure to cross the blood-brain barrier.
Who invested in Dynamic Drug Discovery
1 investor across 1 round
See all investors in Dynamic Drug Discovery
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 31, 2022
Amount
$0.1M
Investors
Questions about Dynamic Drug Discovery
Who invested in Dynamic Drug Discovery?
Dynamic Drug Discovery has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dynamic Drug Discovery raised?
Dynamic Drug Discovery has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dynamic Drug Discovery last raise money?
Dynamic Drug Discovery's most recent round on record is a Seed, in Oct 2022.
What does Dynamic Drug Discovery do?
Based in Daejeon, South Korea, and founded in 2022, Dynamic Drug Discovery formerly known as Dementia Drug Discovery, operates as a pharmaceutical company that develops DAPPD, a drug treatment.
Where is Dynamic Drug Discovery headquartered?
Dynamic Drug Discovery is headquartered in Daejeon-City, South Korea.
Which VCs invest in companies like Dynamic Drug Discovery?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Dynamic Drug Discovery's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Dynamic Drug Discovery? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.